Brazil Deal

The Brazilian government has scrapped the import and distribution of 4 million jabs of India's Bharat Biotech's Covaxin following the country's decision to dismiss the clinical trials and the request for Emergency Use Authorization. "The Collegiate Board of Anvisa unanimously decided on July 27  to provisionally suspend the exceptional and temporary authorization for import and distribution of the vaccine against Covid-19", said the National… read-more